aTYR PHARMA (ATYR) Total Debt (2014 - 2020)
aTYR PHARMA's (ATYR) quarterly Total Debt came in at $3.1 million in Q3 2020, down 71.08% YoY from $10.6 million in Q4 2019, and down 38.48% on a QoQ basis from $5.0 million in Q2 2020.
aTYR PHARMA (ATYR) Total Debt (2014 - 2020) Analysis & Trends
aTYR PHARMA (ATYR) has 7 years of Total Debt data on file, last reported at $3.1 million in Q3 2020.
- Quarterly Total Debt fell 71.08% year-over-year to $3.1 million in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $3.1 million (down 71.08% YoY) and the FY2019 annual result came in at $8.7 million, down 45.5% from the prior year.
- Total Debt fell to $3.1 million in Q3 2020, from $5.0 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $20.0 million in Q1 2018 to a low of $2.6 million in Q3 2016.
- A 5-year average of $11.2 million and a median of $10.6 million in 2019 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2017 — Total Debt soared 458.56% — and 2020, when it tumbled 71.08%.
- Tracing ATYR's Total Debt over 5 years: stood at $9.5 million in 2016, then soared by 106.89% to $19.7 million in 2017, then declined by 18.76% to $16.0 million in 2018, then slumped by 45.5% to $8.7 million in 2019, then tumbled by 64.97% to $3.1 million in 2020.
- The last three Total Debt figures came in at $3.1 million (Q3 2020), $5.0 million (Q2 2020), and $6.9 million (Q1 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.34 Bn |
| 10 | aTYR PHARMA | 49.54 Mn | -7.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 3.06 Mn |
| Jun 30, 2020 | 4.98 Mn |
| Mar 31, 2020 | 6.87 Mn |
| Dec 31, 2019 | 8.74 Mn |
| Sep 30, 2019 | 10.59 Mn |
| Jun 30, 2019 | 12.42 Mn |
| Mar 31, 2019 | 14.23 Mn |
| Dec 31, 2018 | 16.03 Mn |
| Sep 30, 2018 | 17.81 Mn |
| Jun 30, 2018 | 19.57 Mn |
| Mar 31, 2018 | 19.98 Mn |
| Dec 31, 2017 | 19.73 Mn |
| Sep 30, 2017 | 14.75 Mn |
| Jun 30, 2017 | 14.58 Mn |
| Mar 31, 2017 | 9.57 Mn |
| Dec 31, 2016 | 9.54 Mn |
| Sep 30, 2016 | 2.64 Mn |
| Jun 30, 2016 | 3.49 Mn |
| Mar 31, 2016 | 4.32 Mn |
| Dec 31, 2015 | 5.14 Mn |